Skip to main content
. Author manuscript; available in PMC: 2019 Jan 25.
Published in final edited form as: Neurobiol Aging. 2017 Apr 12;56:87–99. doi: 10.1016/j.neurobiolaging.2017.04.003

Fig. 10.

Fig. 10.

VGB treatment significantly decreased spontaneous activity while increasing driven rates. For the mid- and high-frequency tonotopic regions, spontaneous activity (A) was significantly decreased (****p < 0.0001, *p < 0.05) following VGB treatment. The maximum tone-evoked spike rates (B) showed significant increases for all frequencies following treatment (****p < 0.0001). Abbreviation: VGB, vigabatrin.